Home About us Current issue Back issues Submission Instructions Advertise Contact Reader Login  

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 2044 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   1998| October-December  | Volume 9 | Issue 4  
    Online since February 26, 2008

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
EDITORIALS
Hypertension in Pregnancy: Presentation, Management and Outcome - A Retrospective Analysis of 135 Cases
Magdi M Hussein, Jacob M.V Mooij, Haysam Roujouleh
October-December 1998, 9(4):416-424
PMID:18408311
In view of continuous controversies regarding hypertension in pregnancy and lack of reports on this subject in Saudi Arabia, we retrospectively studied 135 episodes of hypertension in pregnancy in 123 patients over a 9-years period. Fifty-one (37.8%) were primiparas, the remaining were multiparas from 2 nd up to 14 11 pregnancy. Of the multiparas, 44% had a history of pregnancy induced hypertension, 26% of chronic hypertension, and 13% of diabetes mellitus. " HELLP"-syndrome occurred in nine and eclampsia in four pregnancies. There were 10 foetal deaths, eight of them presented on admission. Chronic hypertension and diabetes mellitus approached significance as risk factors for foetal death (logistic regression analysis). For the whole group, the time of delivery was the only factor with significant impact on the Apgar score (multiple regression analysis), with an additional negative influence of diabetes mellitus and intravenous hydralazine in the multiparas. When the patients with chronic hypertension and diabetes mellitus were not included, hydralazine lost its significance. The finding suggests that intravenous hydralazine should be given in multiparas with caution, particularly in the presence of chronic hypertension and diabetes mellitus. There was a significant relation of the birth weight to the time of delivery, the serum levels of total protein and, especially in multiparas, of uric acid, confirming the importance of these factors as markers of the severity of pregnancy induced hypertension. The hypertension persisted in patients not known to have chronic hypertension in 9.6% of pregnancies during a follow-up ranging from 2 months up to 9 years.
  3,851 568 -
ORIGINAL ARTICLES
Outcome of Congenital Hydronephrosis in Qatar
Tayseer S Saad, Jamal Al-Zamer, Ghalia M.H Al-Thani, Dawod Al-Khateeb, Mariam Salman
October-December 1998, 9(4):430-434
PMID:18408313
Three hundred and eleven patients diagnosed to have congenital hydronephrosis proven by postnatal ultrasonography in a ten-year period between 1987 and 1996 were studied retrospectively. These were classified into mild degree of hydronephrosis in H (64%), moderate in 94 (30%) and severe in 18 (6%) patients, according to first post natal sonography and depending on the measurement of the anterio-posterior transverse diameter of the pelvi-calyceal system. Significant obstructive uropathy was documented in 66 patients by Technetium-Diethylene triamine penta acetic acid renogram (Tc99m DTPA Renogram Vesicoureteric reflux was found in 22 patients by voiding cysto-urethrogram. On follow­up the hydronephrosis regressed spontaneously in 99 (31.8%), was stable in 167 (53.6%) and needed operative intervention in 45 (14.4%) patients. The types of surgical operations were pyeloplasty in 49% and ureteric re-implantation in 27%. Fifteen (83%) of the children with severe hydronephrosis and 32 (34%) of the moderate hydronephrosis group were operated o while none of the children with the mild form required operative intervention. We recommend ultrasound follow-up for mild hydronephrosis and a coordinated approach and work-up for congenital moderate and severe hydronephrosis. Surgery should only be considered if renal function is affected.
  3,714 270 -
COUNTRY REPORT
Renal Replacement Therapy in Sultanate of Oman
Hamoud Al-Marhuby
October-December 1998, 9(4):459-460
PMID:18408319
  3,597 351 -
CASE REPORT
Sarcoidosis with Partial Reversibility of Renal Failure: Two Case Reports with Review of Literature
Ahmed H Mitwalli, Hassan Abu-Aisha, Jamal Al-Wakeel, Nawaz Ali Memon, Abdullah Al-Mobeireek, Sameer O Huraib
October-December 1998, 9(4):451-456
PMID:18408317
Sarcoidosis is one of the granulomatus disorders affecting many organ systems of the body. Renal impairment in sarcoidosis is rare and occurs usually as a result of long standing hypercalcemia or hypercalciuria with nephrocalcinosis or renal stones. Sarcoid glomerulopathy and tubulo-interstitial granulomatus involvement have been described. We report two cases of sarcoidosis, the first with interstitial nephritis and anterior uveitis without evidence of granuloma. The patient was normocalcemic and normocalciuric. The second case presented with nephritic range proteinuria and severe renal insufficiency with a history of recurrent parotid swelling seven years before diagnosis. Renal biopsy showed non-caseating granulomas in the tubulo-interstitial region. Both patients showed good response to steroid therapy, however, there is still residual renal insufficiency six months after therapy. In conclusion, renal sarcoidosis although a rare presentation, should be considered in the presence of extra-renal manifestation of sarcoidosis as it is amenable to treatment.
  3,580 314 -
EDITORIALS
Osteodystrophy in Chronic Renal Failure Patients
Patrick C D'Haese, Marie Madeleine Couttenye, Marc E De Broe
October-December 1998, 9(4):397-415
  2,949 215 -
ORIGINAL ARTICLES
Neurological Disorders in Renal Transplant Recipients
Ghormullah Al Ghamdi, Adnan Awada, Danlami Z Tanimu, Sameer O Huraib, Saleh Abu Romeh, Khaja Quadri, Waleed Al Khudair, Aamir Iqbal
October-December 1998, 9(4):435-439
PMID:18408314
The charts of 175 renal transplant recipients were retrospectively reviewed. The mean duration of follow up since the transplantation was 4.17 ± 1.66 years. Apart from cyclosporin induced tremor, which occurred almost in all patients, 22 patients (12.5%) had neurological disorders during their follow up (mean annual incidence of 3%). Eight patients had epileptic seizures, seven had strokes, four had neurological infections, two developed a pseudotumor cerebri syndrome, two neuropathies, one myopathy and one conus medullaris infarction. This study demonstrates that neurological disorders are not uncommon in renal transplant recipients and that their mechanisms are variable and may be related to the underlying diseases such as hypertension and diabetes; to the operation itself; to the side effects of immunosuppression agents or rarely, they can accompany graft rejection.
  2,215 378 -
REVIEW ARTICLE
Understanding Immunoglobulin IgA Nephropathy
E Nigel Wardle
October-December 1998, 9(4):444-450
PMID:18408316
  1,970 329 -
COUNTRY REPORT
Renal Replacement Therapy in Bahrain
Sameer Al Arrayed
October-December 1998, 9(4):457-458
PMID:18408318
  2,012 201 -
BRIEF COMMUNICATION
Fasting During the First Year of Transplantation: Is it Safe?
Messaoud Ouziala, Samia Ouziala, Abdelkader Bellaoui, Mohamed Drif
October-December 1998, 9(4):440-443
PMID:18408315
During the month of Ramadan 1417H we studied 14 patients all transplanted with live related kidneys. All the patients were transplanted between one and seven months before the month of Ramadan. All the patients were on azathioprine and prednisolone and the mean plasma creatinine level was 95 ± 15 µmol/L. They all completed fasting the month of Ramadan successfully. Medical evaluation showed that there was no clinical adverse effect. There was no significant change in serum values of creatinine, calcium, protein, sodium, potassium, chloride, HC03, or liver function tests. There was, however, a significant elevation of total plasma proteins, urea, uric acid, hemoglobin, triglycerides, cholesterol, urinary sodium and potassium, concentration (p=<0.05). Our study shows that fasting in Ramadan during the first year of transplantation is possible, nevertheless further studies with large number of patients are necessary to confirm this specially in patients receiving cyclosporine.
  1,962 234 -
ORIGINAL ARTICLES
Incidence of Treated End-Stage Renal Disease in Asir Region, Southern Saudi Arabia
Mohammed Al-Homrany, Mostafa Abolfotoh
October-December 1998, 9(4):425-430
PMID:18408312
Incidence of treated end-stage renal disease (t-ESRD) in Saudi Arabia is not well documented and only few reports are available. This study was conducted to determine the incidence of t-ESRD in Asir region. The study period included January 1995 to December 1995. All new cases admitted for chronic dialysis treatment in all MOH­hospitals with a diagnosis of ESRD were included. There were 114 Saudi and 10 non-Saudi Patients. Among the 114 Saudi patients, there were 64 (56.1%) males and 50 (43.9%) females. Mean age 47.86 ± 19.86 years (range 9-90 years). The overall incidence of t­ESRD was 214.9 pmp. Age adjusted incidence for males and females were 243 pmp and 186 pmp, respectively. There were no differences between males and females (X 2 =2.019, p = <0.05). The majority of the patients (41.2%) did not have definitive diagnosis. Among the known causes, glomerulonephritis was diagnosed or suspected in 56.7%, diabetes was the cause of ESRD in 16.4% of the cases. This is the highest incidence of ESRD ever reported in Saudi Arabia. Geographical, environmental, genetical factors may have been contributing factors.
  1,802 240 -
LETTERS TO THE EDITOR
Acquired Renal Cysts: The Other Side of the Coin
PT Subramanian
October-December 1998, 9(4):462-463
PMID:18408321
  1,138 168 -
Radionuclide Assessment of Patients with Urinary Tract Infection and Vesico-Ureteral Reflux Using Tc­-99m-Dimercaptosuccinic Acid
MB Abdurrahman
October-December 1998, 9(4):463-463
PMID:18408322
  970 148 -
Salt Excretion and Hypertension
PT Subramanian
October-December 1998, 9(4):461-461
PMID:18408320
  868 140 -
  My Preferences